

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Artificial Pancreas Devices Systems market is projected to grow from US$ 100.7 million in 2024 to US$ 199.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.1% during the forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Covers:
This report presents an overview of global market for Artificial Pancreas Devices Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Pancreas Devices Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Artificial Pancreas Devices Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Pancreas Devices Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Pancreas Devices Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Pancreas Devices Systems sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Artificial Pancreas Devices Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Pancreas Devices Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Artificial Pancreas Devices Systems Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Pancreas Devices Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Market by Application
1.3.1 Global Artificial Pancreas Devices Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts 2019-2030
2.2 Global Artificial Pancreas Devices Systems Revenue by Region
2.2.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Artificial Pancreas Devices Systems Revenue by Region (2019-2024)
2.2.3 Global Artificial Pancreas Devices Systems Revenue by Region (2025-2030)
2.2.4 Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2019-2030)
2.3 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts 2019-2030
2.4 Global Artificial Pancreas Devices Systems Sales by Region
2.4.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Artificial Pancreas Devices Systems Sales by Region (2019-2024)
2.4.3 Global Artificial Pancreas Devices Systems Sales by Region (2025-2030)
2.4.4 Global Artificial Pancreas Devices Systems Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Artificial Pancreas Devices Systems Sales by Manufacturers
3.1.1 Global Artificial Pancreas Devices Systems Sales by Manufacturers (2019-2024)
3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artificial Pancreas Devices Systems in 2023
3.2 Global Artificial Pancreas Devices Systems Revenue by Manufacturers
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers (2019-2024)
3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Artificial Pancreas Devices Systems Revenue in 2023
3.3 Global Key Players of Artificial Pancreas Devices Systems, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Artificial Pancreas Devices Systems Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Artificial Pancreas Devices Systems, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Artificial Pancreas Devices Systems, Product Offered and Application
3.8 Global Key Manufacturers of Artificial Pancreas Devices Systems, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Artificial Pancreas Devices Systems Sales by Type
4.1.1 Global Artificial Pancreas Devices Systems Historical Sales by Type (2019-2024)
4.1.2 Global Artificial Pancreas Devices Systems Forecasted Sales by Type (2025-2030)
4.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2019-2030)
4.2 Global Artificial Pancreas Devices Systems Revenue by Type
4.2.1 Global Artificial Pancreas Devices Systems Historical Revenue by Type (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Forecasted Revenue by Type (2025-2030)
4.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Pancreas Devices Systems Price by Type
4.3.1 Global Artificial Pancreas Devices Systems Price by Type (2019-2024)
4.3.2 Global Artificial Pancreas Devices Systems Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Artificial Pancreas Devices Systems Sales by Application
5.1.1 Global Artificial Pancreas Devices Systems Historical Sales by Application (2019-2024)
5.1.2 Global Artificial Pancreas Devices Systems Forecasted Sales by Application (2025-2030)
5.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2019-2030)
5.2 Global Artificial Pancreas Devices Systems Revenue by Application
5.2.1 Global Artificial Pancreas Devices Systems Historical Revenue by Application (2019-2024)
5.2.2 Global Artificial Pancreas Devices Systems Forecasted Revenue by Application (2025-2030)
5.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Price by Application
5.3.1 Global Artificial Pancreas Devices Systems Price by Application (2019-2024)
5.3.2 Global Artificial Pancreas Devices Systems Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Artificial Pancreas Devices Systems Market Size by Type
6.1.1 US & Canada Artificial Pancreas Devices Systems Sales by Type (2019-2030)
6.1.2 US & Canada Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
6.2 US & Canada Artificial Pancreas Devices Systems Market Size by Application
6.2.1 US & Canada Artificial Pancreas Devices Systems Sales by Application (2019-2030)
6.2.2 US & Canada Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
6.3 US & Canada Artificial Pancreas Devices Systems Market Size by Country
6.3.1 US & Canada Artificial Pancreas Devices Systems Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Artificial Pancreas Devices Systems Sales by Country (2019-2030)
6.3.3 US & Canada Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Artificial Pancreas Devices Systems Market Size by Type
7.1.1 Europe Artificial Pancreas Devices Systems Sales by Type (2019-2030)
7.1.2 Europe Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
7.2 Europe Artificial Pancreas Devices Systems Market Size by Application
7.2.1 Europe Artificial Pancreas Devices Systems Sales by Application (2019-2030)
7.2.2 Europe Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
7.3 Europe Artificial Pancreas Devices Systems Market Size by Country
7.3.1 Europe Artificial Pancreas Devices Systems Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019-2030)
7.3.3 Europe Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Artificial Pancreas Devices Systems Market Size
8.1.1 China Artificial Pancreas Devices Systems Sales (2019-2030)
8.1.2 China Artificial Pancreas Devices Systems Revenue (2019-2030)
8.2 China Artificial Pancreas Devices Systems Market Size by Application
8.2.1 China Artificial Pancreas Devices Systems Sales by Application (2019-2030)
8.2.2 China Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Artificial Pancreas Devices Systems Market Size by Type
9.1.1 Asia Artificial Pancreas Devices Systems Sales by Type (2019-2030)
9.1.2 Asia Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
9.2 Asia Artificial Pancreas Devices Systems Market Size by Application
9.2.1 Asia Artificial Pancreas Devices Systems Sales by Application (2019-2030)
9.2.2 Asia Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
9.3 Asia Artificial Pancreas Devices Systems Sales by Region
9.3.1 Asia Artificial Pancreas Devices Systems Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Artificial Pancreas Devices Systems Revenue by Region (2019-2030)
9.3.3 Asia Artificial Pancreas Devices Systems Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Market Size by Type
10.1.1 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Market Size by Application
10.2.1 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Sales by Country
10.3.1 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Artificial Pancreas Devices Systems Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Medtronic Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Bigfoot Biomedical
11.2.1 Bigfoot Biomedical Company Information
11.2.2 Bigfoot Biomedical Overview
11.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bigfoot Biomedical Recent Developments
11.3 Beta Bionics
11.3.1 Beta Bionics Company Information
11.3.2 Beta Bionics Overview
11.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beta Bionics Recent Developments
11.4 Admetsys
11.4.1 Admetsys Company Information
11.4.2 Admetsys Overview
11.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Admetsys Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Admetsys Recent Developments
11.5 Insulet
11.5.1 Insulet Company Information
11.5.2 Insulet Overview
11.5.3 Insulet Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Insulet Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Insulet Recent Developments
11.6 Tandem Diabetes Care
11.6.1 Tandem Diabetes Care Company Information
11.6.2 Tandem Diabetes Care Overview
11.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tandem Diabetes Care Recent Developments
11.7 Defymed
11.7.1 Defymed Company Information
11.7.2 Defymed Overview
11.7.3 Defymed Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Defymed Artificial Pancreas Devices Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Defymed Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Artificial Pancreas Devices Systems Industry Chain Analysis
12.2 Artificial Pancreas Devices Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artificial Pancreas Devices Systems Production Mode & Process
12.4 Artificial Pancreas Devices Systems Sales and Marketing
12.4.1 Artificial Pancreas Devices Systems Sales Channels
12.4.2 Artificial Pancreas Devices Systems Distributors
12.5 Artificial Pancreas Devices Systems Customers
13 Market Dynamics
13.1 Artificial Pancreas Devices Systems Industry Trends
13.2 Artificial Pancreas Devices Systems Market Drivers
13.3 Artificial Pancreas Devices Systems Market Challenges
13.4 Artificial Pancreas Devices Systems Market Restraints
14 Key Findings in The Global Artificial Pancreas Devices Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Ìý
Ìý
*If Applicable.